These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

540 related articles for article (PubMed ID: 23742830)

  • 41. Prospective evaluation of procalcitonin in adults with febrile neutropenia after haematopoietic stem cell transplantation.
    Ortega M; Rovira M; Filella X; Almela M; Puig de la Bellacasa J; Carreras E; Mensa J
    Br J Haematol; 2004 Aug; 126(3):372-6. PubMed ID: 15257709
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients.
    Koch A; Voigt S; Kruschinski C; Sanson E; Dückers H; Horn A; Yagmur E; Zimmermann H; Trautwein C; Tacke F
    Crit Care; 2011; 15(1):R63. PubMed ID: 21324198
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The utility of proadrenomedullin and procalcitonin in comparison to C-reactive protein as predictors of sepsis and bloodstream infections in critically ill patients with cancer*.
    Debiane L; Hachem RY; Al Wohoush I; Shomali W; Bahu RR; Jiang Y; Chaftari AM; Jabbour J; Al Shuaibi M; Hanania A; Pravinkumar SE; Schuetz P; Raad I
    Crit Care Med; 2014 Dec; 42(12):2500-7. PubMed ID: 25083975
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Soluble urokinase-type plasminogen activator receptor (suPAR) in patients with acute pancreatitis (AP) - Progress in prediction of AP severity.
    Lipinski M; Rydzewska-Rosolowska A; Rydzewski A; Cicha M; Rydzewska G
    Pancreatology; 2017; 17(1):24-29. PubMed ID: 27914940
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Biomarkers and molecular analysis to improve bloodstream infection diagnostics in an emergency care unit.
    Loonen AJ; de Jager CP; Tosserams J; Kusters R; Hilbink M; Wever PC; van den Brule AJ
    PLoS One; 2014; 9(1):e87315. PubMed ID: 24475269
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Soluble urokinase plasminogen activator receptor (suPAR) levels in healthy pregnancy and preeclampsia.
    Toldi G; Bíró E; Szalay B; Stenczer B; Molvarec A; Rigó J; Vásárhelyi B; Bekõ G
    Clin Chem Lab Med; 2011 Nov; 49(11):1873-6. PubMed ID: 21722073
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of CRP and procalcitonin for etiological diagnosis of fever during febrile neutropenia in hematology patients- an experience from a tertiary care center in Northern India.
    Halder R; Seth T; Chaturvedi PK; Mishra P; Mahapatra M; Pati HP; Tyagi S; Saxena R
    Blood Cells Mol Dis; 2020 Sep; 84():102445. PubMed ID: 32480243
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Soluble urokinase plasminogen activator receptor (suPAR) in acute care: a strong marker of disease presence and severity, readmission and mortality. A retrospective cohort study.
    Rasmussen LJ; Ladelund S; Haupt TH; Ellekilde G; Poulsen JH; Iversen K; Eugen-Olsen J; Andersen O
    Emerg Med J; 2016 Nov; 33(11):769-775. PubMed ID: 27590986
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The predictive value of soluble urokinase plasminogen activator receptor (SuPAR) regarding 90-day mortality and 12-month neurological outcome in critically ill patients after out-of-hospital cardiac arrest. Data from the prospective FINNRESUSCI study.
    Jalkanen V; Vaahersalo J; Pettilä V; Kurola J; Varpula T; Tiainen M; Huhtala H; Alaspää A; Hovilehto S; Kiviniemi O; Kuitunen A; Tenhunen J;
    Resuscitation; 2014 Nov; 85(11):1562-7. PubMed ID: 25193800
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Soluble urokinase plasminogen activator receptor levels reflect organ damage in systemic lupus erythematosus.
    Enocsson H; Wetterö J; Skogh T; Sjöwall C
    Transl Res; 2013 Nov; 162(5):287-96. PubMed ID: 23916811
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Elevated soluble urokinase plasminogen activator receptor (suPAR) predicts mortality in Staphylococcus aureus bacteremia.
    Mölkänen T; Ruotsalainen E; Thorball CW; Järvinen A
    Eur J Clin Microbiol Infect Dis; 2011 Nov; 30(11):1417-24. PubMed ID: 21479972
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Plasma Soluble Urokinase Plasminogen Activator Receptor Levels in Systemic Lupus Erythematosus Patients.
    Zaitoon YA; Shehab AA; Mohamed NA; Morad CS; Yassine EM
    Egypt J Immunol; 2018 Jan; 25(1):35-43. PubMed ID: 30242996
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Soluble Urokinase Plasminogen Activator Receptor: A New Biomarker in the Pediatric Intensive Care Unit.
    El-Mekkawy MS; Saleh NY; Sonbol AA
    Indian J Pediatr; 2016 Jul; 83(7):661-9. PubMed ID: 26960717
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Plasma level of soluble urokinase plasminogen activator receptor (suPAR) predicts long-term mortality after first acute alcohol-induced pancreatitis.
    Aronen A; Aittoniemi J; Huttunen R; Nikkola A; Nikkola J; Limnell O; Nordback I; Sand J; Laukkarinen J
    Eur J Intern Med; 2019 Jun; 64():72-75. PubMed ID: 31060962
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The relationship between levels of plasma-soluble urokinase plasminogen activator receptor (suPAR) and presence of migraine attack and aura.
    Yılmaz N; Yılmaz M; Sirin B; Yılmaztekin S; Kutlu G
    J Recept Signal Transduct Res; 2017 Oct; 37(5):447-452. PubMed ID: 28553881
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of procalcitonin, neopterin, C-reactive protein, IL-6 and IL-8 as a diagnostic marker of infection in patients with febrile neutropenia.
    Prat C; Sancho JM; Dominguez J; Xicoy B; Gimenez M; Ferra C; Blanco S; Lacoma A; Ribera JM; Ausina V
    Leuk Lymphoma; 2008 Sep; 49(9):1752-61. PubMed ID: 18661397
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Could soluble urokinase plasminogen receptor (suPAR) be used as a diagnostic biomarker for ventilator-associated pneumonia?
    Sunnetcioglu A; Sunnetcioglu M; Adıyaman F; Binici I; Soyoral L
    Clin Respir J; 2017 Nov; 11(6):925-930. PubMed ID: 26683264
    [TBL] [Abstract][Full Text] [Related]  

  • 58. suPAR as a prognostic biomarker in sepsis.
    Donadello K; Scolletta S; Covajes C; Vincent JL
    BMC Med; 2012 Jan; 10():2. PubMed ID: 22221662
    [TBL] [Abstract][Full Text] [Related]  

  • 59. IL-10 combined with procalcitonin improves early prediction of complications of febrile neutropenia in hematological patients.
    Vänskä M; Koivula I; Jantunen E; Hämäläinen S; Purhonen AK; Pulkki K; Juutilainen A
    Cytokine; 2012 Dec; 60(3):787-92. PubMed ID: 22902948
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diagnostic value of sepsis biomarkers in hematopoietic stem cell transplant recipients in a condition of high prevalence of gram-negative pathogens.
    Stoma I; Karpov I; Uss A; Rummo O; Milanovich N; Iskrov I
    Hematol Oncol Stem Cell Ther; 2017 Mar; 10(1):15-21. PubMed ID: 27793578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.